Pressure BioSciences, Inc.
PBIO · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 20.8% | 11.8% | -24.4% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 10.5% | 33.2% | -6.8% | -55.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -827.9% | -748.3% | -1,108.7% | -305.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,687.2% | -2,311.9% | -3,170.7% | -1,516.2% |
| EPS Diluted | -0.15 | -0.22 | -0.44 | -0.288 |
| % Growth | 31.8% | 50% | -52.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |